The Verge Science
2 April 2026
It’s not easy to get depression-detecting AI through the FDA
Why It Matters for ITAD
New technologies may create opportunities or challenges for equipment processing.
For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person's speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some elements may even find a second life […]
Key Takeaways
- • It’s not easy to get depression-detecting AI through the FDA.
